California CRE News In Your Inbox.

Sign up for Connect emails to stay informed with CRE stories that are 150 words or less.

Sub Markets

Property Sectors


California  + Bay Area  + Healthcare  | 
Report: Seattle Life Sciences Growth Powers On

CushWake: Bay Area Life Science Market Sees Major Growth

The Bay Area life science market, already the largest in the nation, has seen exponential growth  in the last five years, according to a Cushman & Wakefield report. Building inventory has grown by 21%, but demand is outpacing existing supply in most regions 2-to-1. 

Real estate developers are working to keep up with the demand, as the current construction pipeline includes 2.7 million square feet of projects, 53% higher than in 2020. Of the 426,000 square feet of space due to be delivered this year, 76% is already pre-leased.

The fly in the ointment is current volatility in the equity markets, which is creating a cash crunch for biotech companies whose market cap has fallen below their cash on hand. Nonetheless, the Bay Area market continues to be a magnet for life sciences investment, with over $8.1 billion in venture capital funding in 2022 so far. 

The Cushman & Wakefield report concludes that despite the economic volatility, the ongoing influx of life sciences capital should continue to drive demand for lab space, ensuring that new spec space delivered will be quickly snapped-up.


Inside The Story

About Mark Nieto

Mark comes to ConnectCRE with an extensive background as a business and news reporter in San Francisco radio, as well as 35 years as a traffic reporter on several stations including KGO, KNBR, KCBS and KFRC. As a business reporter, Mark covered the tech world in Silicon Valley where he became familiar with real estate transactions in the hot Bay Area marketplace. He attended San Jose State University with a BA in Radio and TV Broadcasting and currently resides in the Lake Tahoe area where he gets to frequently enjoy all of his favorite activities: Golfing, Fishing, Hiking and Skiing.

  • ◦Economy
New call-to-action
New call-to-action